TRAITEMENT DE LA FIBROSE AU MOYEN DE LIGANDS DE FXR

• 收藏
• 分享

专利权人:

Intercept Pharmaceuticals; Inc.

发明人:

申请号：

EP16196645.2

公开号：

EP3175855A1

申请日:

2005.03.14

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the famesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a cholestatic condition. The invention also provides pharmaceutical compositions containing an effective amount of an FXR ligand and kits for dispensing the pharmaceutical compositions.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/